التفاصيل البيبلوغرافية
| العنوان: |
Radiopaque drug-eluting embolisation beads as fiducial markers for stereotactic liver radiotherapy. |
| المؤلفون: |
Beaton, Laura, Daly, Mairead, Tregidgo, Henry FJ, Grimes, Helen, Moinuddin, Syed, Stacey, Chris, Znati, Sami, Hague, Julian, Bascal, Zainab A, Wilde, Paul E, Cooper, Sarah, Bandula, Steven, Lewis, Andrew L, Clarkson, Matthew J, Sharma, Ricky A |
| المصدر: |
British Journal of Radiology; Feb2022, Vol. 95 Issue 1130, p1-9, 9p |
| مصطلحات موضوعية: |
STEREOTACTIC radiotherapy, CONE beam computed tomography, COLORECTAL liver metastasis, FOUR-dimensional imaging, STEREOTAXIC techniques, IMAGE-guided radiation therapy, REGORAFENIB |
| مستخلص: |
To determine the feasibility of using radiopaque (RO) beads as direct tumour surrogates for image-guided radiotherapy (IGRT) in patients with liver tumours after transarterial chemoembolisation (TACE). A novel vandetanib-eluting RO bead was delivered via TACE as part of a first-in-human clinical trial in patients with either hepatocellular carcinoma or liver metastases from colorectal cancer. Following TACE, patients underwent simulated radiotherapy imaging with four-dimensional computed tomography (4D-CT) and cone-beam CT (CBCT) imaging. RO beads were contoured using automated thresholding, and feasibility of matching between the simulated radiotherapy planning dataset (AVE-IP image from 4D data) and CBCT scans assessed. Additional kV, MV, helical CT and CBCT images of RO beads were obtained using an in-house phantom. Stability of RO bead position was assessed by comparing 4D-CT imaging to CT scans taken 6–20 days following TACE. Eight patients were treated and 4D-CT and CBCT images acquired. RO beads were visible on 4D-CT and CBCT images in all cases and matching successfully performed. Differences in centre of mass of RO beads between CBCT and simulated radiotherapy planning scans (AVE-IP dataset) were 2.0 mm mediolaterally, 1.7 mm anteroposteriorally and 3.5 mm craniocaudally. RO beads in the phantom were visible on all imaging modalities assessed. RO bead position remained stable up to 29 days post TACE. RO beads are visible on IGRT imaging modalities, showing minimal artefact. They can be used for on-set matching with CBCT and remain stable over time. The role of RO beads as fiducial markers for stereotactic liver radiotherapy is feasible and warrants further exploration as a combination therapy approach. [ABSTRACT FROM AUTHOR] |
|
Copyright of British Journal of Radiology is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder